Peregrine Capital Management LLC Lowers Position in Danaher Corporation $DHR

Peregrine Capital Management LLC lowered its holdings in Danaher Corporation (NYSE:DHR) by 30.5% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,657 shares of the conglomerate’s stock after selling 1,605 shares during the period. Peregrine Capital Management LLC’s holdings in Danaher were worth $722,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Sierra Ocean LLC increased its position in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 76 shares during the last quarter. Red Tortoise LLC increased its position in shares of Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares during the last quarter. Smallwood Wealth Investment Management LLC bought a new position in shares of Danaher during the 1st quarter valued at about $31,000. Ramirez Asset Management Inc. bought a new position in shares of Danaher during the 2nd quarter valued at about $40,000. Finally, Costello Asset Management INC bought a new position in shares of Danaher during the 1st quarter valued at about $41,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 11.20% of the company’s stock.

Danaher Trading Down 1.9%

Shares of DHR stock opened at $216.89 on Wednesday. The stock has a market capitalization of $153.20 billion, a PE ratio of 44.72, a P/E/G ratio of 3.39 and a beta of 0.77. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23. The business has a 50-day moving average of $203.06 and a 200 day moving average of $199.03. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.17. The company had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.Danaher’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, sell-side analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is 26.39%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on DHR. TD Cowen increased their price objective on Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. JPMorgan Chase & Co. increased their price objective on Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Robert W. Baird set a $247.00 price objective on Danaher in a research report on Wednesday, October 22nd. Wells Fargo & Company restated a “positive” rating on shares of Danaher in a report on Thursday, October 23rd. Finally, Rothschild & Co Redburn restated a “neutral” rating and set a $220.00 target price (down from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Eighteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $243.39.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.